2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.

Ian N OlverRebecca Clark-SnowChristina Halgaard Bruvik Ruhlmann Maria-Angeles Garcia-Del-Barrio Florian Scotté Bernardo Leon RapoportFranziska Jahn

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2023)

There is insufficient data to change the current guidelines. Future studies should seek to more accurately determine the risk of emesis with LEC beyond the emetogenicity of the chemotherapy to include patient-related risk assessment.

Keyphrases

clinical practice
risk assessment
locally advanced
human health
case report
electronic health record
heavy metals
current status
big data
squamous cell carcinoma
chemotherapy induced
radiation therapy
case control
climate change